Edgewise Therapeutics Correlations

EWTX Stock  USD 32.08  0.12  0.37%   
The current 90-days correlation between Edgewise Therapeutics and Ikena Oncology is 0.09 (i.e., Significant diversification). The correlation of Edgewise Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Edgewise Therapeutics Correlation With Market

Significant diversification

The correlation between Edgewise Therapeutics and DJI is 0.09 (i.e., Significant diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Edgewise Therapeutics and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Edgewise Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
For more information on how to buy Edgewise Stock please use our How to Invest in Edgewise Therapeutics guide.

Moving together with Edgewise Stock

  0.76BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.69NAMS NewAmsterdam PharmaPairCorr
  0.63PMVP Pmv PharmaceuticalsPairCorr
  0.77ABEO Abeona TherapeuticsPairCorr
  0.69SGMO Sangamo Therapeutics Buyout TrendPairCorr
  0.76AVTE Aerovate TherapeuticsPairCorr
  0.87CRVS Corvus PharmaceuticalsPairCorr

Moving against Edgewise Stock

  0.96FDMT 4D Molecular TherapeuticsPairCorr
  0.84NKTX Nkarta Inc Buyout TrendPairCorr
  0.81MRK Merck Company Fiscal Year End 6th of February 2025 PairCorr
  0.72RGNX RegenxbioPairCorr
  0.64JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.64INKT Mink TherapeuticsPairCorr
  0.58PEPG PepGenPairCorr
  0.4PIRS Pieris PharmaceuticalsPairCorr
  0.37MREO Mereo BioPharma GroupPairCorr
  0.9BDTX Black Diamond TherapPairCorr
  0.85ADAP Adaptimmune TherapeuticsPairCorr
  0.65STOK Stoke TherapeuticsPairCorr
  0.57AFMD Affimed NVPairCorr
  0.49COLL Collegium PharmaceuticalPairCorr
  0.36ANEB Anebulo PharmaceuticalsPairCorr
  0.31ACRV Acrivon Therapeutics,PairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
SCPHELYM
TPSTELYM
MCRBELYM
SCPHTPST
MISTRNXT
MCRBSCPH
  
High negative correlations   
LUMOTPST
LUMOELYM
LUMOMCRB
LUMOSCPH
MISTSCPH
MISTELYM

Risk-Adjusted Indicators

There is a big difference between Edgewise Stock performing well and Edgewise Therapeutics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Edgewise Therapeutics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

Edgewise Therapeutics Corporate Management

Badreddin EdrisCoFounder DirectorProfile
John MooreGeneral CounselProfile
Behrad DerakhshanChief OfficerProfile
Marc MDChief OfficerProfile
John JDGeneral CounselProfile